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Summary 
During development, thymocytes express a number of genes typical for activated peripheral T 
lymphocytes, including granzymes. We have now analyzed by reverse transcription-polymerase 
chain reaction (RT-PCR), immunohistochemistry, and cytochemistry  fetal liver cells and thymocytes 
at various developmental stages for the expression of granzyme A-G genes. At days 13-17 of 
gestation, only granzyme B but none of the other granzymes is expressed in fetal liver. In the 
most immature, Pgp-l+IL2Rc~-,  thymocyte subpopulation mRNAs for granzymes A-C but 
not for granzymes D-G are detectable. Upon further differentiation via Pgp-1-  IL-2Ko~ + into 
more mature Pgp-l-IL-2Rc~-  thymocytes the level of expression of granzymes A, B,  and C 
gradually declines reaching its lowest level at the CD4+8 + double positive stage. In fetal thymic 
lobes depleted of lymphoid cells by treatment with deoxyguanosine, no transcripts for granzymes 
A, B, and C were found indicating that the PCR signals are derived exclusively from early precaxrsor 
T/natural  killer  (NK)  lineage cells  rather  than  from residual  stromal  elements.  In  mature 
CD4+CD8 -  and CD4-CD8 + thymocytes, granzyme B mRNA is found at similar levels in 
both subsets  whereas granzyme A mRNA is expressed selectively in the CD4-CD8 + subset. 
Enzymatic activity of granzyme A  was only seen in a fraction of CD4-CD8 +  thymocytes 
negative for  heat  stable  antigen  (HSA)  but  not  in  the  more immature HSA +  fraction of 
CD4-CD8 § thymocytes. The data suggest that (a) granzyme B is a pro-thymocyte marker for 
all T/NK lineage cells; (b) granzyme A transcripts are associated with thymocytes  with the potential 
to develop into the CD8 + lineage; and (c) granzyme A  enzymatic activity is only expressed 
in the most mature CD4-CD8 + stage, suggesting that granzyme proteins are not involved in 
early stages  of thymocyte development. 
I 
nteraction of activated T  and NK cells with target cells 
leads to exocytosis of cytoplasmic granules into the inter- 
cellular space (1). These organeUes contain a variety of effector 
molecules including a family of highly homologous serine 
proteinases termed granzymes (2).  In the mouse, seven dis- 
tinct granzymes, A-G, have been isolated so far from long- 
term cultured T cell lines (3). Although the secretion of gran- 
zymes during target cell lysis suggests the involvement in 
T/NK cell effector functions, their exact role remains to be 
determined (4). Recent experiments showed that (a) a gran- 
zyme A-specific serine proteinase inhibitor suppresses chro- 
mium release from target cells (5, 6); (b) granzymes A and 
B induce apoptosis and DNA fragmentation in the presence 
of perforin (7-9); and (c) T cells from granzyme B-/- mice 
are unable to induce rapid DNA fragmentation in target cells 
(10). These results indicate that both enzymes are involved 
in the lethal process of target cell lysis. For granzyme A, ad- 
ditional functions such as involvement in extravasation of ac- 
tivated T cells, control of virus replication, and B cell prolifer- 
ation have been suggested (11, 12). 
With the exception of granzyme B, granzymes are found 
only in activated but not resting T  cells (13, 14).  In vivo, 
sensitized T cells mainly express mRNAs for granzymes A 
and B, only marginally for granzyme C, but none for the 
other granzymes (13, 15). In situ hybridization and immuno- 
histochemical analysis  showed that granzyme A  and/or B 
are upregulated during viral and bacterial infections and auto- 
immune reactions as well as during  tissue rejection after 
transplantation (16). These findings were taken as evidence" 
that granzymes are reliable markers for activated T/NK cells 
(16,  17). 
It was therefore surprising when granyzme A- and B-specific 
mRNAs were also detected in thymocytes, predominantly 
in immature subpopulations by in situ hybridization (18). 
However, more recent reports on similar expression patterns 
for various genes in antigen-activated T  cells and in imma- 
ture thymocytes suggest a mnlti-phasic induction of individual 
genes during T cell ontogeny (19, 20). We have now studied 
the expression of granzymes A-G in fetal liver and thymocyte 
subpopulations  by KT-PCK,  immunohistochemistry, and 
cytochemistry. The data demonstrate that granzyme A and 
B genes are differentially transcribed during T  cell matura- 
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Volume 181  February  1995  755-763 tion. Whereas in fetal liver only granzyme B is transcribed, 
early thymocyte stages  contain mKNAs for granzymes A, 
B, and C. At the double positive (DP) stage,  all granzyme 
transcription is very low. Either of the mature single positive 
(SP) subsets transcribe the granzyme B gene but granzyme 
A  transcripts are only present in CD8 +CD4-  cells.  Enzy- 
matic activity of granzyme A  is detected only in the most 
mature CD8+CD4 -  cells,  suggesting that granzyme tran- 
scription reflects lineage potential rather than the require- 
ment of functional gene products during development. 
Materials and Methods 
M/c~  13-17-d-old pregnant female BALB/c mice were obtained 
from the specific  pathogen-free breeding facility at the Max-Planck- 
Institute  for Immunobiology. 
Monoclonal Antibodies.  Anti-CD3e  antibody  145-2Cll  (21), 
hamster IgG, was isolated from culture supernatants by affinity 
chromatography using a Protein A column (Pharmacia, Freiburg, 
Germany). For flow cytometry, labeled anti-CD8  (53.6-7), anti- 
CD4 (RM-4-5),  anti-CD3e  (500A2), anti-Pgp-1 (IM7) (all pur- 
chased from Pharmingen, Hamburg, Germany), and fluoresceinated 
anti-IL-2Kc~ antibody 5A2 (22) were used. 
Fetal Tkymic Organ Cultures.  Fetal  thymic lobes were prepared 
from fetuses at day 14 of gestation.  They were cultured on filter 
discs floating on 1 ml of IMDM supplemented with 10% selected 
FCS, 2% glutamine,  and 1% Penicillin/Streptomycin in 12-well 
dishes (Costar Corp., Cambridge, MA) at 37~  in 7% CO2/air, 
as described by Jenkinson et al. (23). For antibody treatment, the 
lobes were suspended for 2 h in medium supplemented with 50 
#g/ml  anti-CD3  mAb  and  subsequently  placed on filter discs 
floating on the same medium until analysis. Control lobes were 
supplemented with normal hamster IgG. Exposure to antibodies 
was started after 6 d of culture. Cultures  were terminated 3, 5, 
or 8 h after addition of anti-CD3  mAbs. For depletion of hemo- 
poietic cells, fetal thymic lobes were treated for 5 d with deoxy- 
guanosine has described (24). Treated lobes did not reconstitute 
during seven  additional days of  culture, suggesting complete deple- 
tion. Thymic rudiments,  consisting  of epithelial cells and non- 
dividing macrophage/monocyte  and dendritic cells (24), yielded 
85% viable cells after dissociation with Trypsin/EDTA. 
Flow Cytometry and Cell Sorting.  Three-color staining was per- 
formed using FITC-, PE-, and biotin-labeled Ab. As a third-color 
Tricolor-conjugated  Streptavidin (Medac, Hamburg, Germany) was 
used. Analytical flow cytometry was performed on a FACscan Plus  | 
(Becton Dickinson, Heidelberg, Germany). Cell sorting was per- 
formed on a FACstar Plus  |  (Becton Dickinson).  Cells were ob- 
tained from day 16 or 17 fetal thymuses, or from adult thymus. 
RT-PCR and Southem Blot Analysis.  Cytoplasmic RNA was pre- 
pared using the Acid Guanidinium-Thiocyanate-Phenol extraction 
method (25). RT-PCR was performed essentially as described (13). 
Briefly, 1 #g of total KNA was subjected to KT in the presence 
of 20 U  RNase  inhibitor  from human  placenta (Boehringer- 
Mannheim, Mannheim, Germany) and 5 U of Superscript reverse 
transcriptase (GIBCO/BRL, Eggenstein, Germany) in 10 mM Tris- 
HC1, pH  9.0,  50 mM  KC1, 0.01%  (wt/vol) gelatin,  1.5  mM 
MgC12, and 0.1%  Triton X-100.  Both primers were added at a 
concentration of 1 #M, and each dNTP (dATE dCTP, dGTP, and 
dTTP; Pharmacia) at 200 #M. The reaction mixture was incubated 
for I h at 42~  then RT was stopped by heat inactivation (5 min, 
95~  After addition of 0.2 U Super-Taq-Polymerase  (Stehelin, 
Basel, Switzerland) and overlaying with 50 #1 mineral oil (Sigma, 
Deisenhofen, Germany) the cDNA was subjected to 35 cycles of 
PCR amplification  as follows: denaturation for 70 s at 94~  primer 
annealing for 2 min at 45~  and primer extension for 2 min at 
72~  For Southern blot analysis, 5 #1 of  PCR products was resolved 
on a 1.5% agarose get and blotted onto a nylon membrane by alka- 
line transfer in 0.5 M NaOH, 1.5 M NaC1 using a vacuum blot- 
ting device (Pharmacia). Filters were hybridized to radiolabded oli- 
gonucleotide probes at l& cpm/ml in 5 x  SSPE, 5 x  Denhardt's 
solution, 0.1% SDS, 10/~g/ml salmon sperm DNA, then washed, 
dried, and exposed to x-ray films. The sequences of the oligonucle- 
otides used as PCK primers and as hybridization probes as well 
as the sizes of the expected PCR products are describedelsewhere 
(13). All PCR experiments were done at least in duplicates. 
Analysis of  BLT-esterase  Activity.  FACS|  thymocytes were 
resuspended in NKH buffer (137 mM NaC1, 5.3 mM KC1, 20 mM 
Hepes) at 106 ceUs/ml, allowed to adhere for 1 h to adhesion slides 
(BioRad, Muenchen, Germany), blocked with NKH, 0.2% BSA 
for 5 rain, and finally fixed with ethanol for 5 rain. To assay for 
BLT-esterase  activity, a freshly prepared solution of  0.5 mg/ml Fast 
Blue BB salt, 100 #M N-o~-Benzyloxy-t-Lysyl-Thiobenzyl-Ester 
(BLT; both from Sigma) was added to the cells. After 15 min of 
incubation at room temperature, the cells  were counterstained with 
hemalaun solution (Merck, Darmstadt,  Germany) and inspected 
microscopically. The frequency of cells positive for granzyme A 
enzymatic activity was calculated from the analysis of 1,000 cells 
per thymocyte subpopulation. 
Immunohistochemistry of Cwosections.  4-6-#m cryosections of 
fetal thymus were fixed in acetone. Endogeneous peroxidase ac- 
tivity was inhibited by incubating the sections for 20 rain in TBS 
(0.1 M Tris, 0.1  mM NaC1) pH 7.6,  and 0.03%  H202.  After 
blocking with TBS, 1% FCS and 2*/0 nonfat dry milk, the sec- 
tions were incubated with the primary antibodies for 1 h. The fol- 
lowing primary antibodies were used: mouse anti-mouse CD8 bio- 
tinylated (clone 19.178, IgG2A), rat anti-mouse granzyme A (clone 
7.1, IgG; 26). Subsequently, the sections were incubated with ei- 
ther streptavidin-peroxidase (Dianova) or goat anti-rat Ig-alkaline 
phosphatase for 30 or 45 rain, respectively, and after washing ei- 
ther TBS, 0.5 mg/ml diaminobenzidine (Sigma) or 0.1 M Tris (pH 
8.2), 0.5 mg/ml naphtol, 50 mM levanisol, and 1 mg/ml Fast Red 
(all from Sigma) was added. The staining procedure was controlled 
microscopically and the nuclei were counterstained with Mayer's 
hemalaun (Merck). At least 10 sections per fetal thymus were in- 
spected. 
Results and Discussion 
Expression of Granzymes  A-G  in  Thymocyte  Subpopula- 
tions.  During early T  cell development, bone marrow (or 
fetal liver-)-derived precursor cells enter the thymus where 
they develop into mature SP CD4 + or CD8 + T  cells (27). 
This maturation involves a process of differential gene ex- 
pression and rearrangement of the TCRa and 3  gene loci. 
The earliest precursors express Pgp-1 and Fc~RII/III. They 
do not express CD4 or CD8 at high levels, and the TCR 
genes are still in germline configuration. These cells acquire 
the a  chain of the IL-2 receptor (IL-2Rc0, lose Pgp-1 and 
FcyKII/III, and start to rearrange the TCRB locus. After 
successful rearrangement, the thymocytes express an imma- 
ture TCR which drives the cells to downregulate IL-2Kc~ 
and subsequently to mature to the DP CD4 +  8" stage. This 
is accompanied by a burst of cell divisions (27). Interestingly, 
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cytes. Fetal thymocytes from day 16 of gestation were separated into Pgp- 
1  +ID2R~- (FGP-1  +), Pgp-1  -Ib2Roe  + (IL2Ra+), Pgp-1  -I1-2Roe- (PGP- 
1-), or from day 17 of gestation into double negative (DN) and double 
positive (DP) thymocytes. Thymocytes from adult mice were separated 
into TCR.hig  h and TCRlow thymocytes, and the TCR.hig  h cells were fur- 
ther  subdivided into  CD4+CD8 -  (C/M +) and CDS+CD4 -  (CD8 +) 
thymocytes. RNA from CTLL 1.3E6 (+) and from the thymoma line 
EL4F15 (-) was used as positive and negative control, respectively.  Note 
that granzyme B is expressed  at low levels in EL4F15 as shown previously 
(13). Total RNA  was  isolated from  the  sorted  cells and  granzymes 
A-G-spedfic mRNAs were amplified  by KT-PCR. The amplification  prod- 
ucts were blotted onto nylon membranes and hybridized to 32p-labeled 
oligonucleotide probes specific for each of the seven granzymes. Filters 
were exposed for 30 min (A), 6 h (B), and 16 h (C). HPKT blots were 
exposed for 20 min in all cases. 
very early thymocytes express many proteins that are consid- 
ered activation markers of mature T  cells, such as CD25, in- 
terceUular adhesion molecule 1, and CD59 (19). The activa- 
tion of these genes is not regulated by the immature TCR 
/3-CD3 complex as it was also observed in Rag-2-deficient 
mice (19).  However, it is possible that activation occurs by 
CD3 complexes expressed before TCR 3  gene rearrangement 
as previously demonstrated in Rag-l-deficient mice (28, 29). 
From earlier studies it was known that granzymes A  and B 
are also expressed in DN thymocytes (18). By in situ hybrid- 
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ization  it  was  shown  that  "~8%  of IL-2Ra +  thymocytes, 
and  "~,50%  of IL-2Kol-  thymocytes  express  granzyme A 
mRNA.  Very few of these immature double negative (DN) 
thymocytes express mKNA  for granzyme B (3%). The pur- 
pose of this study was to analyze the expression patterns of 
all known  routine  granzymes  (A-G)  in  more  detail. 
To this  end,  we sorted thymocytes from  16- or  17-d-old 
fetuses  in  Pgp-I+IL-2Rot -,  Pgp-l-IL-2Ra +,  and  Pgp- 
1- IL-2Rcr-  (all DN) and in DP CD4 +  8 + populations  and 
analyzed total RNA for the presence of transcripts for gran- zymes A-G by RT-PCR. Sorting included gating for scatter 
parameters that exclude macrophage/monocytes and dendritic 
cells. The amount of RNA present in the reactions was stan- 
dardized to equal amounts of RNA encoding hypoxanthine- 
guanine  phosphoribosyl  transferase  (HPRT). 
From the seven granzymes, only mRNAs for granzymes 
A, B, and C were detectable in various thymocyte subpopu- 
lations (Fig.  1). Highest expression ofmRNA for granzymes 
A  and  B  was  observed in  the  most  immature  Pgp-l+I1 - 
2Rot-  thymocyte subpopulation.  During  further  matura- 
tion into Pgp-1-I1-2Rot § and Pgp-1- I1-2Rot-, the mRNA 
levels of both granzymes decreased, and transcripts  were hardly 
detectable in DP thymocytes (a weak signal for granzyme A 
was seen after exposure of 70 h,  data not shown).  As Pgp- 
1 +  I1-2P,  ot- thymocytes do not undergo functional rearrange- 
ment of the TCR genes, it can be concluded that granzymes A, 
B, and C  are transcribed independent  of TCR c~/B or 3'//t 
gene expression in this thymocyte subpopulation. The possi- 
bility that granzyme gene transcription is merely correlated 
with  the proliferation  status of the  thymocytes is unlikely 
since large DP thymocytes are rapidly cycling, but contain 
low amounts of granzyme A and B and no granzyme C-G 
transcripts. 
To exclude the possibility that the PCR signals for gran- 
zymes A, B, and C are derived from a minor contaminating 
population of non-T/NK lineage thymocytes, thymic lobes 
from day 14 of gestation were incubated in the presence or 
absence of deoxyguanosine. This treatment results in the deple- 
tion of lymphoid cells but the survival of stromal elements, 
including  macrophage/monocytes,  dendritic cells,  and epi- 
thelial cells (24). As seen in Fig. 2, mRNAs for granzymes 
A-C were only detectable in cell populations of undepleted 
(Thy,  -)  but not  depleted  (Thy,  +)  thymic lobes.  These 
Figure  2.  Analysis  of granzyme expression in T/NK lineage and non 
T/NK lineage thymocytes.  Day 14 fetal thymic lobes  were  either cultured 
alone (Thy-) or in the presence of deoxyguanosine  (Thy+). Cells from 
untreated thymic lobes  and from thymic rudiments were analyzed  for the 
presence of granzyme A, B, and C-specific  mRNA by RT-PCR as de- 
scribed in the legend to Fig. 1. The blots were exposed  for 16 h. HPRT 
blot was exposed for 20 min. 
results provide evidence that non-T/NK lineage thymocytes 
do not  transcribe  the genes for granzymes  A-C. 
NK cells also express granzymes A  and B (30),  and NK 
precursors are contained within the earliest  Pgp-l+IL-2Rot- 
thymocyte population (31). It is most probable that in these 
early DN  cells transcription  of both granzymes  occurs in 
precursors of both the NK and T  cell lineages.  The more 
mature  IL-2Rot +  and  IL-2Rot-Pgp-1-  DN  thymocytes, 
however, have lost the capacity to mature into NK cells, but 
continue to transcribe  granzyme A and B genes. This strongly 
indicates  that at the late DN stage the two messages are solely 
generated  in  the  T  cell lineage. 
To analyze granzyme A-G gene transcription in positively 
selected SP thymocytes, we sorted thymocytes from adult mice 
into  CD3hiCD4 + SP and CD3hiCD8 + SP populations.  As 
seen in Fig.  1, granzyme A  transcripts  were only found in 
CD8 +,  but  not  in  CD4 +  cells.  In  contrast,  mRNAs  for 
granzymes B and C were detectable in both populations. Tran- 
scripts for granzymes D-G were not detectable.  Together with 
the previous finding that in the periphery granzyme A is ex- 
pressed in the majority of CD8 + but only in a fraction of 
CD4 + cells  (32),  the data suggest that  the expression pat- 
tern of granzyme A in the thymus reflects functional com- 
mitment  to  the cytotoxic lineage. 
Granzyme A Protein  Expression,  To further analyze gran- 
zyme A  mRNA  and protein  expression in  the  CD8 + SP 
thymocyte  subpopulation,  TCRh~hCD8 §  SP  thymocytes 
were  separated  into  two  subpopulations  distinguished  by 
the expression of heat  stable antigen  (HSA),  i.e.,  TCRhi~  h 
CD8+HSA +  and  TCRhi~hCD8+HSA -.  HSA  was  shown 
before to be highly expressed on DP and early SP cells, but 
much less on mature thymocytes and peripheral T cells (33). 
Both subpopulations contained similar amounts of gran- 
zyme A mRNA as analyzed by RT-PCR (Fig.  3 A). How- 
ever, granzyme A proteolytic activity was only detected in 
the HSA-  but not HSA + subset (Fig.  3 B) indicating  that 
granzyme A is expressed at the protein level only in the most 
mature CD8 + SP thymocyte subset. Since HSA- and HSA + 
SP  cells  expressed  about  equal  amounts  of granzyrne  A 
mRNA, it is unlikely that the differential expression of en- 
zymatic activity is due to limits in the sensitivity of the assay. 
The frequency of cells containing granzyme A  activity was 
,x,1%  which corresponds to the frequency of granzyme A 
mRNA  expressing  CD4- CD8 +  CD3 +  thymocytes as  de- 
tected by in situ hybridization  (18).  No granzyme A  enzy- 
matic activity was found in any of the more immature thymo- 
cyte subpopulations  tested (data not  shown). 
In addition, cryosections of adult thymus were stained with 
a granzyme A-specific mAb (Fig.  3 C). Only few scattered 
cells positive for granzyme A were seen which were mainly 
associated with the medulla.  No staining was seen in the cortex 
harboring  the majority of immature  thymocytes. Taken  to- 
gether,  these findings indicate that  granzyme A  mRNA is 
expressed at various stages during  thymocyte development 
but is translated into protein only in the most mature CD8 § 
SP subpopulation. 
Expression of Granzymes A-G in Fetal Liver.  Expression 
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protein  expression.  CD8 + CD4- 
HSA +  and  CD8+CD4-HSA -  thy- 
mocytes from adult mice were analyzed 
for the presence of granzyme A-specific 
mRNA  by  ILT-PCR  (A;  16-h  ex- 
posure), or for the presence of granzyme 
A  enzymatic  activity by BLT-esterase 
assay  after fixation on adhesion slides 
(B;  x  1,000).  Cryosections  of  adult 
BALB/c thymus were stained with an 
antigranzyme A  mAb  (C;  x  400). of granzymes in mature cells is restricted to T  and NK cells 
(13, 15, 30). Therefore, it is likely that the early DN thymo- 
cytes transcribing granzyme A-C genes are already committed 
to these lineages.  To test  the possibility that  commitment 
to the T/NK lineage already takes place in the fetal liver,  we 
analyzed RNA from fetal liver from fetuses at  days  13-17 
of gestation for the presence of transcripts for granzymes A-G. 
As shown in Fig. 4, granzyme B mRNA is detectable in fetal 
liver at all days of gestation  tested with  slight  increases  in 
mKNA during the development of the fetuses (at days 13-15 
granzyme B-specific transcripts  were detectable only after 72-h 
exposure,  data not  shown).  No mRNAs for granzymes A 
or  C-G  were detected  even  after prolonged  exposure.  At 
present it is unclear whether among granzymes A-G the gran- 
zyme B gene is transcribed selectively during these early stages 
of development or whether the frequency of ceUs transcribing 
granzyme genes is very low and granzyme B mKNA is more 
abundant than mKNAs derived from the other granzymes. 
Since expression of granzymes  so far has been described to 
be restricted to hematopoietic cells of lymphoid origin and 
within those to T  and NK cells (34-36),  our findings sup- 
port  the  hypothesis  that  the  fetal  liver  already  contains 
precursor cells committed to the T/NK lineage. NK precursor 
activity has been described before in fetal liver cells, which, 
however, was only detectable upon their in vitro stimulation 
with IL-2 (37). Granzyme B may therefore be a useful marker 
for the detection of T/NK committed precursor cells in early 
stages of gestation. 
Granzyme Expression  in Fetal Thymic Organ Cultures.  Since 
granzymes A and B are known to be involved in DNA frag- 
mentation of target cells (7-10) it was possible that these pro- 
teinases play a role during negative selection leading to deple- 
tion of autoreactive thymocytes at the DP stage. According 
to our first  experiments  (Fig.  1),  expression of granzymes 
A and B is particularly low at that  stage compared to more 
immature thymocyte subpopulations. To test the possibility 
that granzymes A and B or any of the other granzymes are 
induced during negative selection,  fetal thymic lobes from 
day 14 of gestation were cultured on filter discs for 6 d, and 
then incubated with anti-CD3 mAbs for an additional 3, 5, 
and 8 h.  Subsequently, the lobes were analyzed for expres- 
sion of granzymes  A-G by RT-PCR. 
Under these conditions only transcripts for granzymes A, 
B, and C but none for any of the other granzymes are found 
(Fig.  5). Comparing the anti-CD3-treated lobes to the con- 
trol lobes no significant  differences are observed. The number 
of DP thymocytes was reduced in the presence of anti-CD3 
mAbs  from  69%  in  control  lobes  to  <58%  in  anti- 
CD3-treated lobes as measured by FACS  |  analysis (data not 
shown). Furthermore,  DNA fragmentation was induced by 
Figure  4.  Analysis  of  expression 
of granzymes A-G in fetal liver. 
Fetal liver was isolated from em- 
bryos at day 13-17 of gestation and 
total RNA from the liver cells was 
analyzed for the presence  of gran- 
zymes A-G-specific  transcripts by 
RT-PCR as described  in the legend 
to Fig. 1. The blots were exposed 
for 30 min (A), and 16 h (B). HPRT 
blots were exposed for 20 min. 
760  Granzyme  Gene Expression during Lymphoid Ontogeny Figure  5.  Analysis  of expression of gran- 
zymes A-G in fetal thymic organ cultures. 
Thymic lobes were cultured on filter discs 
floating  on medium.  After  6 d of  culture, anti- 
CD3 mAbs  were added  for 3, 5, or 8 h. After 
mAb treatment  total RNA was isolated  from 
the lobes  and analyzed  for the presence  of  gran- 
zymes A-G--specific  mRNAs by RT-PCtL  as 
described in the legend  to Fig. 1. Filters  were 
exposed  for 30 min (A), and 16 h (B). (a) Anti- 
CD3 mAb treatment;  (co) treatment  with con- 
trol antibodies (hamster IgG). 
the anti-CD3 treatment as measured by agarose gel electropho- 
resis (data not shown), indicating that negative selection occurs 
under these conditions. 
These findings indicate that granzyme mRNA expression 
is not upregulated during negative selection and argue against 
the involvement of these proteinases in programmed cell death 
during negative selection of thymocytes. This assumption is 
in line with the observation that thymocytes from granzyme 
B  /-  mice undergo normal programmed cell death in re- 
sponse to dexamethasone or staphylococcal enterotoxin B stim- 
ulation (10) and that granzyme A-deficient (Ebnet, K., M. 
Hausmann, F. Lehmann-Grube, J. Golecki, M. Kopf, M. C. 
Lamers, and M. M. Simon, manuscript in preparation)  as well 
as granzyme B-deficient mice (10) show unaltered hemato- 
poiesis  and development of peripheral lymphoid cells. 
Conclusion.  Taken together, our findings show that (a) 
in fetal liver granzyme B transcripts are detectable at days 
13-17  of gestation;  (b)  in the most immature, Pgp-I+IL  - 
2Ro~-, thymocyte subpopulation the genes for granzymes 
A, B, and C  are transcribed; (c) from the two mature thyo 
mocyte subpopulations, only CD4-CD8 + but not CD4 § 
CD8-  cells express granzyme A; and (d) granzyme A pro- 
tein is expressed only by the most mature CD4-CD8 + thy- 
mocytes. 
The finding that fetal liver ceils express transcripts for gran- 
zyme B, a marker for antigen-activated T  cells and mature 
NK cells, suggests that the commitment of hematopoietic 
cells to the T/NK lineage already occurs at this stage of de- 
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velopment. Granzyme B might represent a marker for these 
lineages suitable to study the differentiation  pathways of early 
precursors  of NK and T  ceils. 
The presence of granzyme A, B, and C transcripts in early 
fetal thymocytes is reminiscent of other markers which are 
associated with activated peripheral T  cells but temporarily 
induced in immature TCK- thymocytes (19). It seems very 
likely that the fetal liver/thymic stroma tissues provide the 
activation signals required for the induction or maintenance 
of granzyme A, B, and C mKNA expression.  It remains to 
be determined if the immature CD3 complex expressed be- 
fore TCK/3 rearrangement (28, 29) is involved in this induc- 
tion event. 
The functional relevance of granzymes during T/NK cell 
development is not known. The presence  of mKNAs does 
not necessarily imply the presence of functional proteins and 
our  findings  indicate  that  only  the  most  mature,  i.e., 
CD4-CD8+HSA - , thymocytes express granzyme A as pro- 
tein. The presence of granzyme transcripts in early thymocytes 
may reflect an activation state necessary to start transcription 
and rearrangement of the TCK gene loci. It is unlikely that 
the functional expression of the granzyme proteins is rele- 
vant for T cell maturation. This is supported by the normal 
development of T cells in mice lacking granzyme A (Ebnet, 
K., et al.,  manuscript in preparation) or granzyme B (10). 
In more mature ceils, transcription of genes for granzymes A 
and B is most probably correlated with the functional com- 
mitment to the CD4 + and CD8 + lineages.  Because gran- zyme A is expressed in peripheral CD8 + T  cells only upon 
activation (38),  the expression in  CD8 +  thymocytes may 
correlate with a phase of activation necessary for peripheral 
expansion of newly produced T cells. Alternatively, positive 
selection itself may be accompanied by a state of activation, 
as  suggested  by expression of activation markers  such  as 
CD69 (39). 
From the seven granzymes A-G described so far in the 
mouse, only granzymes A, B, and C  are transcribed during 
early hematopoiesis. The same expression pattern of gran- 
zymes is observed in in vivo activated peripheral T cells (13). 
Transcription of granzyme D-G genes was detectable so far 
only after short-term in vitro culture (14,  15). The stimuli 
required for the induction of granzymes D-G in vivo as well 
as their physiological relevance  are not known. 
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